Lambda Biologics
Search
Profile

The full name

email@vos.com

May. 29, 2025

Top Biotech News (29 May 2025)

Companies are developing in vivo CAR-T therapies that edit immune cells directly in patients, potentially reducing costs from $500k to far less per treatment.

Newsletter

2025
  • May(5)
  • April(4)
  • March(4)
  • February(4)
  • January(5)
2024
  • December(4)
  • November(5)
  • October(4)
  • September(3)
  • August(1)
  • July(4)
  • June(4)
  • May(8)
  • April(1)
  • March(1)

Subscribe
to the latest updates in the newsletter

Connect with Us

By submitting your details, you confirm that you have reviewed and agree with the Lambda Biologics Privacy Policy.